General Information
Revision date
2010-11-02
Product name
Thiacetazone
CAS No.
104-06-3
supplier name
Santa Cruz Biotechnology, Inc
Emergency telephone
+613 9573 3112
Icons in SDS
Company Information
company name
Santa Cruz Biotechnology, Inc
Section 2
SECTION 2: Hazards identification
CHEMWATCH HAZARD RATINGS Min Max Flammability: 1 Toxicity: 2 Body Contact: 0 Min/Nil=0 Low=1 Reactivity: 1 Moderate=2 High=3 Chronic: 2 Extreme=4 CANADIAN WHMIS SYMBOLS EMERGENCY OVERVIEW RISK Harmful if swallowed.
Potential Acute Health Effects
SWALLOWED Accidental ingestion of the material may be harmful; animal experiments indicate that ingestion of less than 150 gram may be fatal or may produce serious damage to the health of the individual. Thiosemicabazones, when used therapeutically, have produced nausea, vomiting, liver damage, skin eruption, anemia, leukopenia and granulocytopenia. EYE Although the material is not thought to be an irritant, direct contact with the eye may cause transient discomfort characterized by tearing or conjunctival redness (as with windburn). Slight abrasive damage may also result. <\p>. SKIN Skin contact is not thought to produce harmful health effects (as classified using animal models). Systemic harm, however, has been identified following exposure of animals by at least one other route and the material may still produce health damage following entry through wounds, lesions or abrasions. <\p>. Open cuts, abraded or irritated skin should not be exposed to this material. Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected. INHALED The material is not thought to produce either adverse health effects or irritation of the respiratory tract following inhalation (as classified using animal models). Nevertheless, adverse effects have been produced following exposure of animals by at least one other route and good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting. Persons with impaired respiratory function, airway diseases and conditions such as emphysema or chronic bronchitis, may incur further disability if excessive concentrations of particulate are inhaled.
Potential chronic health
Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems. Long term exposure to high dust concentrations may cause changes in lung function i.e. pneumoconiosis; caused by particles less than 0.5 micron penetrating and remaining in the lung. <\p>. Antimycobacterial agents (used in the treatment of tuberculosis and leprosy, for example) may produce side-effects when given for prolonged periods. It may be difficult to attribute toxicity to specific agents since treatment regimes often involve the use of two or more drugs. Hypersensitivity reaction may be minor (requiring treatment with antihistamines) or more severe (requiring withdrawal and treatment with steroids). Certain drugs of this class are hepatotoxic whilst others produce neurotoxicity.